Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence

Pulmonary disease (PD) caused by nontuberculous mycobacteria is an emerging infection mainly in countries where the incidence of tuberculosis is in decline. It affects an elderly population, often with underlying chronic lung diseases, but its epidemiology shows significant regional variation. Guide...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Expert review of anti-infective therapy Ročník 11; číslo 10; s. 1065 - 1077
Hlavní autori:	van Ingen, Jakko, Ferro, Beatriz E, Hoefsloot, Wouter, Boeree, Martin J, van Soolingen, Dick
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Informa Healthcare 01.10.2013 Taylor & Francis Expert Reviews Ltd
Predmet:	Aged Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - therapeutic use atypical mycobacteria Clinical Trials as Topic Drug Administration Schedule Drug Dosage Calculations Drug therapy Evidence-Based Medicine Human immunodeficiency virus Humans lung disease Lung diseases Medical case management Mycobacterial infections Mycobacterium abscessus Mycobacterium avium Mycobacterium avium complex Mycobacterium chelonae Mycobacterium fortuitum Mycobacterium Infections, Nontuberculous - drug therapy Mycobacterium Infections, Nontuberculous - microbiology Mycobacterium kansasii Mycobacterium malmoense Mycobacterium xenopi nontuberculous mycobacteria Nontuberculous Mycobacteria - classification Nontuberculous Mycobacteria - drug effects Nontuberculous Mycobacteria - physiology Survival Analysis Treatment Outcome
ISSN:	1478-7210, 1744-8336, 1744-8336
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!